No.

Publication Date

Citing Article

1

2024

Mingzhu Zhai, Weihua Yang, Chen Zou, Shan Du, Benqing Wu, Changshan Wang, Yuanzhi Lu, Yi Zheng. Predictive role of HPGD gene in carcinogenesis and immune environment monitoring in human cervical cancer, Cancer Biomarkers. 2024; 41: 18758592241296277.  https://doi.org/10.1177/18758592241296277

2

2022

Olivia L. Walker, Margaret L. Dahn, Melanie R. Power Coombs, Paola Marcato. The Prostaglandin E2 Pathway and Breast Cancer Stem Cells: Evidence of Increased Signaling and Potential Targeting, Frontiers in Oncology. 2022; 11: 791696.  https://doi.org/10.3389/fonc.2021.791696

3

2021

Weixuan Wang, Changmei Yang, Haiteng Deng. Overexpression of 15-Hydroxyprostaglandin Dehydrogenase Inhibits A549 Lung Adenocarcinoma Cell Growth via Inducing Cell Cycle Arrest and Inhibiting Epithelial-Mesenchymal Transition, Cancer Management and Research. 2021; Volume 13: 8887.  https://doi.org/10.2147/CMAR.S331222

4

2024

Milan Teraiya, Oleg Krokhin, Vincent C. Chen, Hélène Perreault. Cytoplasmic Shotgun Proteomic Points to Key Proteins and Pathways in Temozolomide-Resistant Glioblastoma Multiforme, Journal of Proteome Research. 2024; 23: 465.  https://doi.org/10.1021/acs.jproteome.3c00669

5

2025

SubbaRao V. Tulimilli, Medha Karnik, Anjali Devi S. Bettadapura, Olga A. Sukocheva, Edmund Tse, Gowthamarajan Kuppusamy, Suma M. Natraj, SubbaRao V. Madhunapantula. The tumor suppressor role and epigenetic regulation of 15-hydroxyprostaglandin dehydrogenase (15-PGDH) in cancer and tumor microenvironment (TME), Pharmacology & Therapeutics. 2025; 268: 108826108826.  https://doi.org/10.1016/j.pharmthera.2025.108826

6

2022

Yunfei Xu, Haoduo Qiao, Shun Yang, Lin Zhou, Yao Zhao, Qing Xu, Shuying Miao, Dun Yuan, Jie Zhao, Ying Liu. 15-Hydroxyprostaglandin Dehydrogenase Is a Predictor of Stroke-Associated Pneumonia, Frontiers in Neurology. 2022; 13: 893624.  https://doi.org/10.3389/fneur.2022.893624